On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 2 Article 4
Back to Table of Contents

Eurosurveillance, Volume 7, Issue 2, 09 January 2003

Citation style for this article: Molesworth AM. Variant Creutzfeldt-Jakob disease in the United Kingdom in 2002. Euro Surveill. 2003;7(2):pii=2146. Available online:

Variant Creutzfeldt-Jakob disease in the United Kingdom in 2002

Anna Molesworth (, Public Health Laboratory Service Communicable Disease Surveillance Centre, London, England.

The end of 2002 has seen a total of 129 definitive or probable cases of variant Creutzfeldt-Jakob disease (vCJD) reported in the United Kingdom (UK) (1). Elsewhere numbers remain small, with 8 cases in Europe (6 in France, 1 in Italy, and 1 in the Republic of Ireland) and a further 2 cases in North America (Canada and the USA).

The latest figures show that in the UK last year 17 people died from vCJD, 3 less than the previous year (see figure). A further 8 cases are still alive. It is, however, too early to conclude the epidemic is waning. To date, all affected people have been methionine homozygotes at codon 129 of the prion protein gene but other genotypes may also be susceptible.

Figure: Deaths of definite and probable vCJD in the UK (data to 6 January 2003)

There is currently no effective treatment for vCJD, which is believed to be caused by exposure to the bovine spongiform encephalopathy (BSE) agent, most plausibly through eating BSE contaminated meat or meat products.


References :
  1. Department of Health. Monthly Creutzfeldt-Jakob disease statistics. Monday 6 January 2003.  (

back to top

Back to Table of Contents

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.